Direct evidence of podocyte damage in cardiorenal syndrome type 2: Preliminary evidence

CardioRenal Medicine

Volumn 5, Issue 2, 2015, Pages 125-134

  Le Jemtel, Thierry H ^a   Rajapreyar, Indranee ^a   Selby, Michael G ^b   Payne, Brian ^a   Barnidge, David R ^b   Milic, Natasa ^b,c   Garovic, Vesna D ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiorenal syndrome; Podocyturia; Proteinuria

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PODOCIN; PROTEIN;

ADULT; ARTICLE; CARDIORENAL SYNDROME; CARDIORENAL SYNDROME TYPE 2; CELL DAMAGE; CONTROLLED STUDY; FEMALE; GLOMERULUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY INJURY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PODOCYTE; PODOCYTE DAMAGE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84928503164     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000375130     Document Type: Article

References (28)

1. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
2. Liang KV, Williams AW, Greene EL, Redfield MM: Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008; 36:S75-S88.
3. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC: Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2012; 81: 40-55.
4. Sarraf M, Masoumi A, Schrier RW: Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 2009; 4: 2013-2026.
5. Tang WH, Mullens W: Cardiorenal syndrome in decompensated heart failure. Heart 2010; 96: 255-260.
6. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH: Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 2010; 16: 49-54.
7. Brezis M, Rosen S: Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995; 332: 647-655.
8. Shrestha K, Shao Z, Singh D, Dupont M, Tang WH: Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 2012; 110: 1329-1335.
9. Winterberg PD, Lu CY: Acute kidney injury: the beginning of the end of the dark ages. Am J Med Sci 2012; 344: 318-325.
10. Valente MA, Damman K, Dunselman PH, Hillege HL, Voors AA: Urinary proteins in heart failure. Prog Cardiovasc Dis 2012; 55: 44-55.
11. Damman K, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL: The cardiorenal syndrome in heart failure. Prog Cardiovasc Dis 2011; 54: 144-153.
12. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008; 4: 39-45.
13. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP: Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007; 196: 320e1-320e7.
14. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285:F40-F48.
15. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J: Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16: 1733-1741.
16. Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum JA, Ronco C, McCullough PA: Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 117-136.
17. Rafiq K, Noma T, Fujisawa Y, Ishihara Y, Arai Y, Nabi AH, Suzuki F, Nagai Y, Nakano D, Hitomi H, Kitada K, Urushihara M, Kobori H, Kohno M, Nishiyama A: Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation 2012; 125: 1402-1413.
18. Otaki Y, Watanabe T, Shishido T, Takahashi H, Funayama A, Narumi T, Kadowaki S, Hasegawa H, Honda S, Netsu S, Ishino M, Arimoto T, Miyashita T, Miyamoto T, Konta T, Kubota I: The impact of renal tubular damage, as assessed by urinary beta2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure. Circ Heart Fail 2013; 6: 662-668.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
20. Garovic VD, Craici IM, Wagner SJ, White WM, Brost BC, Rose CH, Grande JP, Barnidge DR: Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia. Nephrol Dial Transplant 2013; 28: 1555-1561.
21. Barr JR, Maggio VL, Patterson DG, Jr., Cooper GR, Henderson LO, Turner WE, Smith SJ, Hannon WH, Needham LL, Sampson EJ: Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 1996; 42: 1676-1682.
22. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD: Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 2013; 61: 1289-1296.
23. Campbell KN, Raij L, Mundel P: Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev 2011; 7: 3-7.
24. Ito S: Cardiorenal syndrome: an evolutionary point of view. Hypertension 2012; 60: 589-595.
25. Rajagopalan S, Bakris GL, Abraham WT, Pitt B, Brook RD: Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies. Hypertension 2013; 62: 444-449.
26. Shankland SJ: The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147.
27. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC: Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 2009; 20: 1041-1052.
28. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ: Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009; 374: 543-550.